FDA Mandates Breast Density Notification for All Mammogram Patients
New rule ensures women are informed about breast density risks and encourages discussions on additional screenings.
Overview
- Effective September 10, 2024, mammogram facilities must notify women about their breast density.
- Dense breast tissue can obscure cancer on mammograms and increase cancer risk.
- 3D mammograms and supplemental screenings such as ultrasounds and MRIs may aid in cancer detection.
- Insurance coverage for supplemental screenings remains inconsistent across states.
- Effective patient-doctor communication is crucial to navigate breast cancer screening options.